Catalysts
Catalysts
Figures converted from Indian rupees at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.
The next six months hinge on a single hard date: May 12, 2026 — the FY26 audited-results board meeting that delivers Q4 FY26 numbers, the FY27 guidance check, the third interim dividend, and a near-final reconciliation against the $18.6M fire-insurance cover. This single event resolves both the bull's "double-digit EBITDA exit" thesis and the bear's "guidance has been gutted" thesis simultaneously. Beyond that print the calendar is thin — the August 2026 FY26 annual report and the Q1 FY27 results are real but secondary, and most other items are continuous watchpoints rather than dated decisions. The signal-quality of the calendar is medium: the May print is hard-dated and dollar-impactful, but consensus is built on only two analysts, and the dominant risk variable (the founder's pledge to Tata Capital) does not have a fixed disclosure date.
Hard-dated events (next 6m)
High-impact catalysts
Days to next hard date
Signal quality (1–5)
Ranked Catalyst Timeline
The May 12, 2026 print dominates everything else by a wide margin. It is the only event inside six months that simultaneously resolves earnings power (Q4 EBITDA), capital allocation (3rd interim dividend), forensic credibility (clean vs recovery-flattered EBITDA), and the bull/bear FY27 guidance debate in one shot. Items 2 and 5 are forced follow-throughs from item 1; items 3, 4, 9, 10 are continuous watchpoints that gain weight only if the May print is ambiguous; items 7 and 8 are tail-risk and second-derivative reads, respectively.
Impact Matrix
Most genuinely "resolving" rows are the first three. The FY27 guidance row is information-rich but does not by itself change underwriting — it confirms or denies what May 12 already shows. The wafers row matters more for variant perception than for the binary debate. The GST row is asymmetric: the upside is "no news," the downside is a real surprise.
Next 90 Days
The 90-day calendar is dominated by one event and three continuous reads.
May 12, 2026 — board meeting (FY26 audited + Q4 FY26 + 3rd interim dividend). The market will mark the stock on Q4 EBITDA stripped of insurance recoveries, not headline EPS. Consensus expects 10–12% EBITDA on $59.7–65.0M revenue ($4.0–5.1M PAT); Q3 FY26 printed 7.6% with recoveries above the line. Anything ≥9% clean closes half the gap to Bikaji's 65× multiple; below 8% triggers the third FY27 reset and re-tests the credibility of the January-2026 guidance bridge. The dividend decision is a smaller-but-real signal — a hold or hike means the family expects sustained free cash flow; a cut after FY25's 66% payout would be the loudest "we are not confident" signal possible.
Late May / early June — Q4 FY26 concall. This is where the FY27 $192–203M / 8–9% EBITDA guide either gets reaffirmed with a quantified Modasa-MT and distributor-count bridge, or quietly walked back a third time. Listen for two specific things: (a) the FY28 "normalized double-digit EBITDA" aspiration — if CFO Raithatha attaches numbers to it, that resets the debate from FY27 to FY28; (b) explicit wafer-line and Balaji-pricing-gap framing — wafers are the only growth lever the bear case cannot dismiss.
Continuous — promoter pledge filings (BSE Reg 31 / SAST). The next encumbrance disclosure is on a non-fixed cadence. The reflexive risk: a further 25–30% drawdown from $2.95 (i.e., toward bear $2.13) plausibly triggers margin calls on the 9.72% Tata Capital pledge into a 0.06%-of-mcap ADV market. Why a PM should care now: this is the single largest source of disorderly downside left in the structure that does not show up on the earnings line.
Continuous — palm oil + chana/potato cost watch. CFO commentary in February 2026 already flagged lower chana and potato as a margin offset to packaging inflation; palm at ~$1.17–1.23/kg sits well below the $1.41 peak. A renewed palm spike toward $1.39+ is the cleanest single way the Q4 EBITDA print disappoints versus the "near double-digit" exit-rate guide. Bio-coal switching at Modasa and Nagpur insulates against gas restrictions but not against vegetable-oil price.
The calendar is light beyond May 12 within the 90-day window — no investor day, no scheduled regulatory hearing, no announced M&A, no scheduled lock-up expiry (the 6-month IPO lock-ups already cleared in September 2024). This is a one-event 90 days.
What Would Change the View
The two or three observable signals that would most change the investment debate over the next six months are: (1) Q4 FY26 EBITDA margin stripped of insurance and other exceptionals — the single highest-information print. ≥9% clean validates the bull's "FY24's 12% is the structural mean" thesis and makes the 35× normalized P/E look earned; <8% confirms the bear's "FY24 was an IPO-prep peak" reading and pushes the FY27 bridge into a third reset cycle. (2) Direction of the Tata Capital pledge in the next encumbrance filing — a flat-to-shrinking pledge removes the largest implementation risk for institutional capital and would partly explain why FII holding stopped declining; a third increase confirms the bear's "leveraged founder into illiquid float" tail-risk thesis. (3) Non-Gujarat revenue mix and wafers growth in the Q1 FY27 print (August) — variant perception on this name lives in the wafers franchise (the only +40–48% growth lever) and the four-state footprint that Hiriyur and Kashipur enable; a clear print of >35% non-Gujarat YoY plus sustained 40%+ wafer growth is what would turn this from a fire-recovery trade into a national-brand thesis. Anything else — GST SCN movement, FII/MF flow, the AGM disclosures — is supportive but secondary; the five-yard line of this debate is whether the May 12 EBITDA looks like 12% (Bikaji discount-closer) or 7% (Prataap-style clearing price).